Egetis Therapeutics AB (publ) (STO:EGTX)
5.37
-0.14 (-2.54%)
Aug 1, 2025, 5:29 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 1.93 billion as of August 1, 2025. Its market cap has increased by 28.53% in one year.
Market Cap
1.93B
Enterprise Value
1.76B
Revenue
46.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.37
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 1.93B, an increase of 757.80%. That is a compound annual growth rate of 16.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 1.93B | -23.29% |
Dec 30, 2024 | 2.51B | 54.03% |
Dec 29, 2023 | 1.63B | 7.15% |
Dec 30, 2022 | 1.52B | 37.56% |
Dec 30, 2021 | 1.11B | -10.17% |
Dec 30, 2020 | 1.23B | 15.17% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 102.35B |
Sectra AB | 69.48B |
Getinge AB | 53.34B |
Camurus AB | 42.78B |
Medicover AB | 41.67B |
Asker Healthcare Group AB | 38.24B |
Bonesupport Holding AB | 22.39B |
AddLife AB | 21.08B |